Research advances in kinase enzymes and inhibitors for cardiovascular disease treatment

Autor: Sana Saffour, Faris El-Dahiyat, Rand Shahin, Maha Habash, O. H. Shaheen
Rok vydání: 2017
Předmět:
Zdroj: Future Science OA
ISSN: 2056-5623
DOI: 10.4155/fsoa-2017-0010
Popis: The targeting of protein kinases has great future potential for the design of new drugs against cardiovascular diseases (CVDs). Enormous efforts have been made toward achieving this aim. Unfortunately, kinase inhibitors designed to treat CVDs have suffered from numerous limitations such as poor selectivity, bad permeability and toxicity. So, where are we now in terms of discovering effective kinase targeting drugs to treat CVDs? Various drug design techniques have been approached for this purpose since the discovery of the inhibitory activity of Staurosporine against protein kinase C in 1986. This review aims to provide context for the status of several emerging classes of direct kinase modulators to treat CVDs and discuss challenges that are preventing scientists from finding new kinase drugs to treat heart disease.
Lay abstract Various protein kinase enzymes are distinctly involved in diverse signal pathways involved in regulating cardiac function in health and disease states. In 1986, the inhibitory activity of Staurosporine against protein kinase C was revealed, and since then, the interest in finding active kinase inhibitors for use in medicine has grown. Numerous kinase inhibitors have been synthesized in the last two decades, yet none has found its way to the market as a cardiovascular disease treatment; thus, more scientific efforts are needed in this regard.
Databáze: OpenAIRE